These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1542672

  • 1. Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma.
    Hill JS, Kahl SB, Kaye AH, Stylli SS, Koo MS, Gonzales MF, Vardaxis NJ, Johnson CI.
    Proc Natl Acad Sci U S A; 1992 Mar 01; 89(5):1785-9. PubMed ID: 1542672
    [Abstract] [Full Text] [Related]

  • 2. Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.
    Hiramatsu R, Kawabata S, Tanaka H, Sakurai Y, Suzuki M, Ono K, Miyatake S, Kuroiwa T, Hao E, Vicente MG.
    J Pharm Sci; 2015 Mar 01; 104(3):962-70. PubMed ID: 25546823
    [Abstract] [Full Text] [Related]

  • 3. Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer.
    Hill JS, Kahl SB, Stylli SS, Nakamura Y, Koo MS, Kaye AH.
    Proc Natl Acad Sci U S A; 1995 Dec 19; 92(26):12126-30. PubMed ID: 8618857
    [Abstract] [Full Text] [Related]

  • 4. Application of a novel boronated porphyrin (H₂OCP) as a dual sensitizer for both PDT and BNCT.
    Hiramatsu R, Kawabata S, Miyatake S, Kuroiwa T, Easson MW, Vicente MG.
    Lasers Surg Med; 2011 Jan 19; 43(1):52-8. PubMed ID: 21254143
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of porphyrin C analogues for photodynamic therapy of cerebral glioma.
    Karagianis G, Hill JS, Stylli SS, Kaye AH, Varadaxis NJ, Reiss JA, Phillips DR.
    Br J Cancer; 1996 Feb 19; 73(4):514-21. PubMed ID: 8595167
    [Abstract] [Full Text] [Related]

  • 7. A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model.
    Ceberg CP, Brun A, Kahl SB, Koo MS, Persson BR, Salford LG.
    J Neurosurg; 1995 Jul 19; 83(1):86-92. PubMed ID: 7782856
    [Abstract] [Full Text] [Related]

  • 8. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.
    Ozawa T, Afzal J, Lamborn KR, Bollen AW, Bauer WF, Koo MS, Kahl SB, Deen DF.
    Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):247-52. PubMed ID: 16111595
    [Abstract] [Full Text] [Related]

  • 9. Enhanced boron uptake in RG 2 rat gliomas by electropermeabilization in vivo--a new possibility in boron neutron capture therapy.
    Ceberg CP, Brun A, Mir LM, Persson BR, Salford LG.
    Anticancer Drugs; 1994 Aug 01; 5(4):463-6. PubMed ID: 7949252
    [Abstract] [Full Text] [Related]

  • 10. Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy.
    Dagrosa MA, Viaggi M, Kreimann E, Farías S, Garavaglia R, Agote M, Cabrini RL, Dadino JL, Juvenal GJ, Pisarev MA.
    Thyroid; 2002 Jan 01; 12(1):7-12. PubMed ID: 11838734
    [Abstract] [Full Text] [Related]

  • 11. Photophysics and intracellular distribution of a boronated porphyrin phototherapeutic agent.
    Spizzirri PG, Hill JS, Kahl SB, Ghiggino KP.
    Photochem Photobiol; 1996 Dec 01; 64(6):975-83. PubMed ID: 8972641
    [Abstract] [Full Text] [Related]

  • 12. Intracellular uptake of a new boronated porphyrin EC032.
    Tsurubuchi T, Yamamoto T, Nakai K, Zaboronok A, Yoshida F, Miyakawa M, Shirakawa M, Yamamoto Y, Matsuda M, Matsumura A.
    Appl Radiat Isot; 2009 Jul 01; 67(7-8 Suppl):S94-6. PubMed ID: 19410469
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
    Yokoyama K, Miyatake S, Kajimoto Y, Kawabata S, Doi A, Yoshida T, Asano T, Kirihata M, Ono K, Kuroiwa T.
    J Neurooncol; 2006 Jul 01; 78(3):227-32. PubMed ID: 16557351
    [Abstract] [Full Text] [Related]

  • 15. Uptake of a nido-carboranylporphyrin by human glioma xenografts in athymic nude mice and by syngeneic ovarian carcinomas in immunocompetent mice.
    Kahl SB, Joel DD, Nawrocky MM, Micca PL, Tran KP, Finkel GC, Slatkin DN.
    Proc Natl Acad Sci U S A; 1990 Sep 01; 87(18):7265-9. PubMed ID: 2402507
    [Abstract] [Full Text] [Related]

  • 16. Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading.
    Capuani S, Gili T, Bozzali M, Russo S, Porcari P, Cametti C, Muolo M, D'Amore E, Maraviglia B, Lazzarino G, Pastore FS.
    Appl Radiat Isot; 2009 Jul 01; 67(7-8 Suppl):S34-6. PubMed ID: 19375337
    [Abstract] [Full Text] [Related]

  • 17. Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin.
    Rosenthal MA, Kavar B, Hill JS, Morgan DJ, Nation RL, Stylli SS, Basser RL, Uren S, Geldard H, Green MD, Kahl SB, Kaye AH.
    J Clin Oncol; 2001 Jan 15; 19(2):519-24. PubMed ID: 11208846
    [Abstract] [Full Text] [Related]

  • 18. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF, Yang W, Adams DM, Rotaru JH, Shukla S, Sekido M, Tjarks W, Fenstermaker RA, Ciesielski M, Nawrocky MM, Coderre JA.
    Cancer Res; 2002 Jun 01; 62(11):3159-66. PubMed ID: 12036929
    [Abstract] [Full Text] [Related]

  • 19. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent.
    Matalka KZ, Barth RF, Staubus AE, Moeschberger ML, Coderre JA.
    Radiat Res; 1994 Jan 01; 137(1):44-51. PubMed ID: 8265787
    [Abstract] [Full Text] [Related]

  • 20. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
    Dagrosa MA, Viaggi M, Rebagliati RJ, Batistoni D, Kahl SB, Juvenal GJ, Pisarev MA.
    Mol Pharm; 2005 Jan 01; 2(2):151-6. PubMed ID: 15804189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.